| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |